Venus Remedies Limited (BSE: 526953)
Health Care · Pharmaceuticals · IN
Rs1,730.40
-3.16% today · +249.5% 1Y
Venus Remedies Limited (BSE: 526953) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $241.75M.
Over the last twelve months the share price has gained 249.5%, trading between 423.70 and 2.04K.
Tweenvest scores Venus Remedies Limited across four factors: quality 73/100, value 27/100, growth 80/100, dividend 44/100. Its strongest factor is growth.
526953 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $241.75M
- Revenue (TTM)
- $85.80M
- P/E
- 19.91
- EPS
- 86.89
- Dividend yield
- 0.58%
- Beta (5Y)
- 0.35
- 52-week high
- Rs2,043.15
- 52-week low
- Rs423.70
- Avg volume (3M)
- —
- Shares outstanding
- 13.37M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,251.95 | +0.40% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.12 | +0.03% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $155.00 | +2.88% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.42 | +1.61% |
Figures last refreshed Aug 18, 2026.